LDN 1.5 mg Healing Pharma

What Is LDN 1.5 mg by Healing Pharma? LDN 1.5 mg is a low-dose naltrexone hydrochloride formulation produced by Healing Pharma, a pharmaceutical manufacturer recognised for precision-dosed oral capsule products. Naltrexone hydrochloride is a µ-opioid receptor antagonist — at standard clinical concentrations it is used in opioid-dependence management, but at significantly reduced concentrations it exhibits a distinct pharmacological profile that has attracted substantial interest within the research community. Researchers exploring the broader catalogue available at uksteroidshops.co.uk will find LDN 1.5 mg positioned within a growing class of precisely dosed investigational compounds. Research Applications and Areas of Investigation Low-dose naltrexone has been investigated extensively in preclinical and early-stage clinical models for its interactions with glial cell pathways, toll-like receptor 4 (TLR4) modulation, and endogenous opioid system dynamics. At sub-therapeutic concentrations, transient µ-opioid receptor blockade is hypothesised to produce a rebound upregulation of endorphin production, a mechanism that researchers have examined in the context of neuroinflammation, autoimmune-adjacent models, and chronic pain signalling pathways. Scientists examining these neurochemical mechanisms can browse the full Research Compounds range for complementary investigational agents. Additionally, studies have explored LDN interactions with microglial activation markers and cytokine expression profiles in murine models, making this a multi-faceted compound of interest across immunology and neuroscience disciplines. Product Specifications LDN 1.5 mg Healing Pharma — Technical Specifications Parameter Detail Active Compound Naltrexone Hydrochloride Strength per Capsule 1.5 mg Form Oral Capsule Manufacturer Healing Pharma CAS Number 16590-41-3 Molecular Formula C₂₀H₂₄ClNO₄ Molecular Weight 377.86 g/mol SKU EU14381 Price £26 Storage Room temperature, dry, away from direct light Receptor Target µ-Opioid Receptor (antagonist) Researchers interested in oral-format compounds may also wish to review the oral steroids section for further reference compounds studied in pharmacokinetic absorption models, while those examining injectable delivery mechanisms may find the injectable steroids category a useful comparative resource for bioavailability research. Compliance and Safety Information LDN 1.5 mg Healing Pharma is supplied strictly for in-vitro and laboratory research purposes only. This product is not intended for human consumption, self-administration, or therapeutic use outside of a licensed clinical environment. It must not be used as a substitute for medical advice, diagnosis, or treatment. Purchasers must be aged 18 or over and are solely responsible for ensuring compliance with all applicable local laws and regulations governing the acquisition and use of research compounds. This content is educational in nature and does not constitute medical or dosing guidance.